AQR Capital Management - SYNAGEVA BIOPHARMA CORP ownership

SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103. A total of 84 filers reported holding SYNAGEVA BIOPHARMA CORP in Q4 2013. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of SYNAGEVA BIOPHARMA CORP
ValueSharesWeighting
Q1 2015$322,000
-82.3%
3,300
-83.2%
0.00%
-75.0%
Q4 2014$1,819,000
+78.7%
19,600
+32.4%
0.00%
+33.3%
Q3 2014$1,018,000
+31.2%
14,800
+100.0%
0.00%
+50.0%
Q2 2014$776,000
+66.9%
7,400
+32.1%
0.00%
+100.0%
Q1 2014$465,000
-85.8%
5,600
-89.2%
0.00%
-91.7%
Q3 2013$3,279,000
+609.7%
51,800
+370.9%
0.01%
+500.0%
Q2 2013$462,000
+95.8%
11,000
+115.7%
0.00%
+100.0%
Q4 2012$236,0005,1000.00%
Other shareholders
SYNAGEVA BIOPHARMA CORP shareholders Q4 2013
NameSharesValueWeighting ↓
Baker Brothers Advisors 10,660,432$1,117,213,00013.68%
BB BIOTECH AG 898,476$94,160,0004.47%
SECTORAL ASSET MANAGEMENT INC 516,445$54,123,0002.29%
Ghost Tree Capital, LLC 30,000$3,144,0002.22%
COLUMBIA WANGER ASSET MANAGEMENT LLC 3,521,000$369,001,0001.48%
Pier Capital, LLC 83,493$8,750,0001.24%
ArrowMark Colorado Holdings LLC 197,613$20,710,0000.59%
PALISADE CAPITAL MANAGEMENT, LP 120,779$12,658,0000.31%
FORTALEZA ASSET MANAGEMENT INC/ 5,440$570,0000.26%
Tradeworx Inc. 2,936$308,0000.25%
View complete list of SYNAGEVA BIOPHARMA CORP shareholders